SPONSOR CONTENT BY AMERICAN CANCER SOCIETY CANCER ACTION NETWORK
Scientists are developing a new way to test for multiple cancers at once, which could help detect cancer at earlier stages - when the patient may have more treatment options and a better prognosis. Multi-cancer early detection screenings could revolutionize cancer detection and help more seniors like Rachel rewrite their future by getting treatment early on. Once these tests are FDA-approved, Congress must help seniors access this breakthrough innovation. Tell Congress to support H.R. 1946/S. 1873. Learn more.
Multi-Cancer Early Detection Tests
Get one blood test. Detect up to 10, 20 or even more types of cancer.
That is the potential for a new category of cancer early detection tests currently being developed and tested by scientists. A breakthrough like this could revolutionize the ability to detect cancer at its earliest, most treatable stages, including for dozens of cancers for which there is no current screening test.
They call it a Multi-Cancer Early Detection (MCED) test. We call it an innovative and potentially game-changing advancement for cancer patients.
Now we need to ensure that, if approved by the FDA, millions of people, especially older Americans at higher risk for cancer, will have the test covered by their health insurance plan. We are asking Congress to pass legislation that lays the groundwork for this to happen.
Addressing Health Disparities Through Multi-Cancer Early Detection Tests
Multi-Cancer Early Detection Screening Could Help Reduce Cancer Disparities
Overall cancer mortality rates have been declining for more than two decades in the United States, but racial, socioeconomic, and geographic disparities persist. The availability of multi-cancer screening tests has the potential to address cancer mortality disparities by detecting more cancers earlier in more people.
Cancer disparities occur mostly because of barriers to high quality cancer prevention, early detection, and treatment due to inequities in employment, wealth, education, housing, and standards of living.
A simple blood test may be more accessible and acceptable to patients, thereby extending screening opportunities to traditionally underserved communities. Reducing cancer disparities can only be achieved if there is equitable access to the test in underserved communities, which Medicare coverage can help promote.
New Ad Campaign Calls on Members of Congress to Support Legislation Aiming to Increase Early Cancer Detection
------------------------------Stephen Martin, MD EdMUMass Chan Medical School------------------------------
They're baaaa-ck ... now here to scare seniors:
This demographic is most likely to be overscreened and overdiagnosed and also sustain the greatest harms, as pointed out by the National Cancer Institute just last year:
Scientists are developing a new way to test for multiple cancers at once, which could help detect cancer at earlier stages, when the patient may have more treatment options and a better prognosis. Multi-cancer early detection screenings could help revolutionize cancer detection and help more seniors rewrite their future by getting cancer treatment early on. Once these tests are FDA-approved, Congress must help seniors access this breakthrough innovation. Tell Congress to support H.R. 1946/S. 1873.
Michael A. Bruno, M.D., M.S., F.A.C.R. Professor of Radiology & Medicine
Vice Chair for Quality & Patient Safety
Chief, Division of Emergency Radiology
Penn State Milton S. Hershey Medical Center ( (717) 531-8703 | 6 (717) 531-5737